Prenetics Moves With IM8 Rally; Tuesday Could Show What’s Priced In
Prenetics Global shares closed Friday at $16.77, up 15% from May 18, as U.S. markets reopened after Memorial Day. The company reported Q1 revenue of $36 million, with $33.8 million from its IM8 nutrition line, and raised its 2026 IM8 forecast to $190–$210 million. IM8 is selling about 150,000 servings daily in 43 countries. Prenetics sold its digital-asset stake for $41.3 million and spent $19 million on share buybacks.